Bg pattern

YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION - Radiopharmaceutical precursor in solution

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION - Radiopharmaceutical precursor in solution

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

PACKAGE LEAFLET: INFORMATION FOR THE USER

Yttriga radiopharmaceutical precursor in solution.

Chloride of (90Y) yttrium

Read all of this leaflet carefully before you start using this medicine.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

In this leaflet:

  1. What is Yttriga and what is it used for
  2. Before you use Yttriga
  3. How to use Yttriga
  4. Possible side effects
  5. Storage of Yttriga
  6. Further information

1. What is YTTRIGA and what is it used for

Yttriga is a radioactive medicinal product used in combination with another medicinal product that targets specific cells in the body.

When the target is reached, Yttriga provides tiny doses of radiation to these specific sites.

For more information about the treatment and possible effects caused by the radiolabelled medicinal product, see the package leaflet of the medicinal product used in combination.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Before you use YTTRIGA

Do not use Yttriga:

  • if you are allergic (hypersensitive) to chloride of (90Y) yttrium or any of the other components of Yttriga.
  • if you are pregnant or if there is a possibility that you may be pregnant (see below).

Take special care with Yttriga:

Yttriga is a radioactive medicinal product and is only used in combination with another medicinal product.

Its intended use is not direct administration to patients.

Due to strict laws regarding the use, handling, and disposal of radiopharmaceuticals, this product must be used exclusively in a hospital or similar facility. It must be handled and administered exclusively by qualified and trained personnel for the safe treatment of radioactive materials.

Special care should be taken when administering radioactive medicinal products to children and adolescents (from 2 to 16 years of age).

Use of other medicinal products

Tell your doctor or pharmacist if you are using or have recently used any other medicinal products, including those obtained without a prescription.

The interaction of chloride of (90Y) yttrium with other medicinal products is unknown, as no clinical studies are available.

Pregnancy

Yttriga is contraindicated in pregnancy.

Tell your doctor if there is any possibility that you may be pregnant. If you experience a delay in your menstrual period, you should assume you are pregnant until proven otherwise.

Your doctor will consider the possibility of using alternative techniques that do not involve the use of ionizing radiation.

Women of childbearing age must use effective contraceptive methods during and after treatment.

Breast-feeding

Your doctor will ask you to interrupt breast-feeding.

Ask your doctor or pharmacist for advice before taking any medicinal product.

3. How to use YTTRIGA

Your doctor will not administer Yttriga directly.

Dose.

Your doctor will decide what quantity of Yttriga you will receive for treatment.

Method of administration

YTTRIGA is a radioactive medicinal product used in combination with another medicinal product that targets specific cells in the body and is administered by your doctor.

If Yttriga is administered inadvertently

Yttriga is administered by your doctor after combining it with another medicinal product under strictly controlled conditions. The risk of receiving a possible overdose is small. However, if this occurs, you will receive appropriate treatment from your doctor.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicinal products, Yttriga can cause side effects, although not everybody gets them.

For more information, see the package leaflet of the specific medicinal product that will be radiolabelled.

If you experience any side effect not mentioned in this leaflet or if you experience any of the side effects described as severe, tell your doctor or pharmacist.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicinal product.

5. Storage of YTTRIGA

Keep out of the reach and sight of children.

Do not use Yttriga after the expiry date stated on the label after EXP.

Storage must be carried out in accordance with local regulations for radioactive substances.

Disposal of unused medicinal product and all materials that have come into contact with it will be carried out in accordance with local regulations.

6. FURTHER INFORMATION

What contains Yttriga?

  • The active substance is chloride of (90Y) yttrium.
  • 1 ml of sterile solution contains 0.1-300 GBq of (90Y) yttrium on the reference date and time (equivalent to 0.005-15 micrograms of (90Y) yttrium) (as chloride of (90Y) yttrium).
  • The other components are hydrochloric acid (0.04 M).

Appearance and packaging of Yttriga

Colourless glass type I vial of 3 ml with a V-shaped bottom or a colourless glass type I vial with a flat bottom of 10 ml with a silicone plug, sealed with an aluminium seal.

Radiopharmaceutical precursor in solution.

Transparent and colourless sterile solution

Marketing authorisation holder

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Str. 10

D-13125 Berlin

Germany

Tel +49- 30-941084-280

Fax +49- 30-941084-470

e-mail: [email protected]

Manufacturer

Eckert & Ziegler Radiopharma GmbH

Branch Braunschweig

Gieselweg 1

D-38110 Braunschweig

Germany

You can obtain further information on this medicinal product from the representative of the marketing authorisation holder in your country:

Belgium

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Lithuania

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Bulgaria

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Luxembourg

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Czech Republic

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Hungary

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Denmark

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Malta

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Germany

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Netherlands

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Estonia

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Norway

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Greece

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Austria

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Spain

NUCLIBER, S.A.

C/ Hierro, 33

E-28045 Madrid

Tel: +34 915 062 940

[email protected]

Poland

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

France

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Portugal

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Croatia

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Romania

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Ireland

Advanced Accelerator Applications (UK & Ireland) Ltd.

Edison House, 223-231 Old Marylebone Road,

London, NW1 5QT – UK

Tel: +44 (0)2072585252

[email protected]

Slovenia

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Iceland

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Slovak Republic

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Italy

Campoverde srl

Via Quintiliano, 30

I-20138 Milano

Tel: +39-02-58039045

[email protected]

Finland

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Cyprus

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Sweden

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

Latvia

Eckert & Ziegler Radiopharma GmbH

Robert-Rössle-Straße 10

D-13125 Berlin

Tel: +49-30-941084-280

[email protected]

United Kingdom

Advanced Accelerator Applications (UK & Ireland) Ltd.

Edison House, 223-231 Old Marylebone Road,

London, NW1 5QT – UK

Tel: +44 (0)2072585252

[email protected]

Date of last revision of this leaflet:{MM/YYYY}.

Other sources of information

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu.

The leaflet can be found in all languages of the European Union/European Economic Area on the European Medicines Agency website.

.

Online doctors for YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION - Radiopharmaceutical precursor in solution

Discuss questions about YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION - Radiopharmaceutical precursor in solution, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (11)
Doctor

Daniel Cichi

Family medicine 24 years exp.

Dr Daniel Cichi is a family medicine doctor with over 20 years of clinical experience. He provides online consultations for adults, supporting patients with acute symptoms, chronic conditions, and everyday health concerns that require timely medical guidance. His background includes work in emergency care, ambulance services, and family medicine, which allows him to assess symptoms quickly, identify warning signs, and help patients choose the safest next steps – whether that means home care, treatment adjustment, or in-person evaluation. Patients commonly consult Dr Daniel Cichi for: 

  • acute symptoms: fever, infections, flu-like illness, cough, sore throat, shortness of breath;
  • chest discomfort, palpitations, dizziness, fatigue, and blood pressure concerns;
  • digestive problems: abdominal pain, nausea, diarrhoea, constipation, reflux;
  • sexually transmitted infections, erectile dysfunction;
  • muscle, joint, and back pain, minor injuries, post-traumatic symptoms;
  • chronic conditions: hypertension, diabetes, high cholesterol, thyroid disorders, weight loss, hair loss;
  • review and interpretation of lab tests, imaging reports, and medical documents;
  • medication review and treatment adjustment;
  • medical advice while travelling or living abroad;
  • second opinions and guidance on whether in-person care is needed.

Dr Cichi’s consultations are structured and practical. He focuses on clear explanations, risk assessment, and actionable recommendations, helping patients understand their symptoms and make informed decisions about their health.

Camera Book a video appointment
€55
5.0 (147)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (32)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60
5.0 (4)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
2
...

Frequently Asked Questions

Is a prescription required for YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION - Radiopharmaceutical precursor in solution?
YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION - Radiopharmaceutical precursor in solution requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
Who manufactures YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION - Radiopharmaceutical precursor in solution?
YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION - Radiopharmaceutical precursor in solution is manufactured by Eckert & Ziegler Radiopharma Gmbh. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION - Radiopharmaceutical precursor in solution online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION - Radiopharmaceutical precursor in solution is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION - Radiopharmaceutical precursor in solution?
Other medicines with the same active substance () include LUTATHERA 370 MBq/mL SOLUTION FOR INFUSION, PLUVICTO 1000 MBq/mL Injectable Solution and Perfusion Solution, Xofigo 1100 kBq/ml injectable solution. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media